Hajar Ashrafi

1.1k total citations
40 papers, 803 citations indexed

About

Hajar Ashrafi is a scholar working on Pharmaceutical Science, Molecular Biology and Biomaterials. According to data from OpenAlex, Hajar Ashrafi has authored 40 papers receiving a total of 803 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pharmaceutical Science, 10 papers in Molecular Biology and 9 papers in Biomaterials. Recurrent topics in Hajar Ashrafi's work include Advanced Drug Delivery Systems (12 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advancements in Transdermal Drug Delivery (5 papers). Hajar Ashrafi is often cited by papers focused on Advanced Drug Delivery Systems (12 papers), Nanoparticle-Based Drug Delivery (8 papers) and Advancements in Transdermal Drug Delivery (5 papers). Hajar Ashrafi collaborates with scholars based in Iran, Netherlands and Canada. Hajar Ashrafi's co-authors include Amir Azadi, Leila Pourtalebi Jahromi, Negin Mozafari, Pedram Rafiei, Mehrdad Hamidi, Soliman Mohammadi‐Samani, Reza Heidari, Ramin Ansari, Saeid Daneshamouz and Mohammad‐Ali Shahbazi and has published in prestigious journals such as SHILAP Revista de lepidopterología, International Journal of Pharmaceutics and Journal of Ethnopharmacology.

In The Last Decade

Hajar Ashrafi

35 papers receiving 790 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hajar Ashrafi Iran 17 280 265 187 140 79 40 803
Matilde Durán‐Lobato Spain 13 233 0.8× 316 1.2× 230 1.2× 139 1.0× 46 0.6× 19 715
Amarjitsing Rajput India 15 165 0.6× 309 1.2× 230 1.2× 144 1.0× 37 0.5× 36 837
Asuman Bozkır Türkiye 17 330 1.2× 312 1.2× 358 1.9× 189 1.4× 44 0.6× 61 962
Hakan Eroğlu Türkiye 17 223 0.8× 208 0.8× 182 1.0× 168 1.2× 30 0.4× 50 787
Heba A. Gad Egypt 19 182 0.7× 385 1.5× 173 0.9× 113 0.8× 94 1.2× 42 944
Christine G. Oster Germany 6 222 0.8× 242 0.9× 313 1.7× 166 1.2× 141 1.8× 7 1.1k
Hend Mohamed Abdel‐Bar Egypt 18 244 0.9× 180 0.7× 235 1.3× 131 0.9× 30 0.4× 37 712
Puxiu Wang China 15 200 0.7× 294 1.1× 139 0.7× 134 1.0× 78 1.0× 27 688
Neda Naseri Iran 6 245 0.9× 359 1.4× 334 1.8× 178 1.3× 52 0.7× 8 949
Nazende Günday-Türeli Germany 15 280 1.0× 206 0.8× 217 1.2× 183 1.3× 33 0.4× 30 777

Countries citing papers authored by Hajar Ashrafi

Since Specialization
Citations

This map shows the geographic impact of Hajar Ashrafi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hajar Ashrafi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hajar Ashrafi more than expected).

Fields of papers citing papers by Hajar Ashrafi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hajar Ashrafi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hajar Ashrafi. The network helps show where Hajar Ashrafi may publish in the future.

Co-authorship network of co-authors of Hajar Ashrafi

This figure shows the co-authorship network connecting the top 25 collaborators of Hajar Ashrafi. A scholar is included among the top collaborators of Hajar Ashrafi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hajar Ashrafi. Hajar Ashrafi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Derakhshan, Mohammad Ali, et al.. (2024). A thermoresponsive chitosan-based in situ gel formulation incorporated with 5-FU loaded nanoerythrosomes for fibrosarcoma local chemotherapy. International Journal of Biological Macromolecules. 278(Pt 4). 134781–134781. 6 indexed citations
3.
Mozafari, Negin, Soliman Mohammadi‐Samani, Saeid Daneshamouz, et al.. (2023). Ultrasound-responsive hyaluronic acid hydrogel of hydrocortisone to treat osteoarthritis. International Journal of Biological Macromolecules. 240. 124449–124449. 36 indexed citations
4.
Ahmadi, Fatemeh, et al.. (2023). Platelets and platelet-derived vesicles as an innovative cellular and subcellular platform for managing multiple sclerosis. Molecular Biology Reports. 50(5). 4675–4686. 6 indexed citations
5.
Mozafari, Negin, et al.. (2022). Preparation and in vitro evaluation of controlled release granules of mesalazine for colon targeted drug delivery system. SHILAP Revista de lepidopterología. 1 indexed citations
6.
Mirzaei, Esmaeil, et al.. (2022). Preparation and evaluation of niosomal chitosan-based in situ gel formulation for direct nose-to-brain methotrexate delivery. International Journal of Biological Macromolecules. 213. 1115–1126. 30 indexed citations
7.
Ashrafi, Hajar, et al.. (2020). New Candidate Delivery System for Alzheimer’s Disease: Deferoxamine Nanogels. Biointerface Research in Applied Chemistry. 10(6). 7106–7119. 18 indexed citations
8.
Mozafari, Negin, et al.. (2020). Inflammation: A bridge between diabetes and COVID-19, and possible management with sitagliptin. Medical Hypotheses. 143. 110111–110111. 48 indexed citations
9.
Ashrafi, Hajar, et al.. (2020). Dexamethasone ameliorates Alzheimer’s pathological condition via inhibiting Nf-κB and mTOR signaling pathways. Biointerface Research in Applied Chemistry. 10(4). 5792–5796. 6 indexed citations
10.
Ashrafi, Hajar, Amir Azadi, Soliman Mohammadi‐Samani, Younes Ghasemi, & Saeid Daneshamouz. (2020). Preliminary study for the preparation of fatty acid bioconjugated L-asparaginase micellar nanocarrier as a delivery system for peptide anti-cancer agents. SHILAP Revista de lepidopterología. 6(3). 175–188.
11.
Rezazadeh, Fahimeh, et al.. (2019). Efficacy of Phenytoin Mucoadhesive Tablet versus Mouthwash on Chemotherapy-Induced Oral Mucositis: A Randomized Clinical Trial. SHILAP Revista de lepidopterología. 1 indexed citations
13.
Mohammadi‐Samani, Soliman, et al.. (2018). Controlled-release in-situ gel forming formulation of tramadol containing chitosan-based pro-nanogels. International Journal of Biological Macromolecules. 118(Pt B). 1449–1454. 22 indexed citations
14.
Azadi, Amir, et al.. (2017). A reversed-phase high performance liquid chromatography approach for analysis of 5-Fluorouracil. SHILAP Revista de lepidopterología. 2 indexed citations
15.
Ashrafi, Hajar, et al.. (2017). Traditional neurotherapeutics approach intended for direct nose to brain delivery. Journal of Ethnopharmacology. 209. 116–123. 18 indexed citations
16.
Jahromi, Leila Pourtalebi, Soliman Mohammadi‐Samani, Hajar Ashrafi, & Amir Azadi. (2016). A Reversed-phase High Performance Liquid Chromatography (HPLC) method for bio-analysis of Methotrexate. SHILAP Revista de lepidopterología. 4 indexed citations
17.
Azadi, Amir & Hajar Ashrafi. (2016). Cell organelle-shaped liposomes: A novel approach to present the stable intracellular drug delivery systems. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Hamidi, Mehrdad, Amir Azadi, Pedram Rafiei, & Hajar Ashrafi. (2013). A Pharmacokinetic Overview of Nanotechnology-Based Drug Delivery Systems: An ADME-Oriented Approach. Critical Reviews in Therapeutic Drug Carrier Systems. 30(5). 435–467. 62 indexed citations
19.
Ashrafi, Hajar, Mohsen Amini, Soliman Mohammadi‐Samani, et al.. (2013). Nanostructure l-asparaginase-fatty acid bioconjugate: Synthesis, preformulation study and biological assessment. International Journal of Biological Macromolecules. 62. 180–187. 31 indexed citations
20.
Hamidi, Mehrdad, Mohammad‐Ali Shahbazi, & Hajar Ashrafi. (2012). Drug abuse in sport : doping. Nova Science eBooks.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026